Ad Groups Unfazed by DTC-Drug Debacles

CHARLOTTE, N.C. (AdAge.com) — Even after the Vytorin controversy and Eli Lilly's $1 billion payout to the federal government, the ad industry is standing by its opposition to a two-year moratorium on advertising new drugs directly to consumers.

No Responses to “Ad Groups Unfazed by DTC-Drug Debacles”

Post a Comment